Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio-Techne Corp (NASDAQ:TECH)

106.62
Delayed Data
As of Apr 27
 +0.86 / +0.81%
Today’s Change
91.45
Today|||52-Week Range
117.42
+3.69%
Year-to-Date

Today’s Trading

Previous close105.76
Today’s open105.89
Day’s range105.89 - 107.52
Volume154,734
Average volume (3 months)181,779
Market cap$3.9B
Dividend yield1.20%
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)-3.11%
Earnings growth (this year)-0.92%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+10.34%
P/E ratio50.8
Price/Sales8.43
Price/Book4.48

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+0.40+0.45%
KITEKite Pharma Inc-0.16-0.19%
NBIXNeurocrine Bioscienc...+0.31+0.58%
NKTRNektar Therapeutics+0.14+0.75%
Data as of 04/27/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.93
Annual revenue (last year)$499.0M
Annual profit (last year)$104.5M
Net profit margin20.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles R. Kummeth
CFO, Chief Accounting Officer &
VP-Finance
James T. Hippel
Corporate headquarters
Minneapolis, Minnesota

Forecasts